When was VentriPoint founded?

VentriPoint was founded in 2005 and raised its 1st funding round 5 years after it was founded.

Where is VentriPoint located?

VentriPoint is headquartered in Toronto, Canada.

How many employees does VentriPoint have?

As of May 27, 2025, the latest employee count at VentriPoint is 49.

Is VentriPoint a funded company?

VentriPoint is a funded company, having raised an undisclosed amount across 17 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Mar 30, 2010.

When was the latest funding round of VentriPoint?

VentriPoint's latest funding was a $***** Post IPO round on Feb 04, 2025, with participation from 0 investor.

Where does VentriPoint rank among its competitors?

VentriPoint ranks 5th amongst 73 active competitors, of which 20 are funded. It stands 10th in terms of total funding among its competitors. The most recent competitor to raise funding was LifeLens, which secured $15.1M in Nov, 2025.

Who are the top competitors of VentriPoint?

VentriPoint's top competitors include Eko, HeartFlow and Cleerly. Among them, LifeLens secured the most recent funding round in November, 2025.

VentriPoint - 2026 Company Profile, Funding & Competitors

Company Details

Ventripoint Diagnostics is a medical device company that develops and commercializes its diagnostic tools to monitor patients with heart disease. By using images produced from existing medical imaging systems, the Ventripoint Medical System (VMS), an FDA cleared device, generates heart volumetric measurements and a three-dimensional (3D) model. Its solution produces heart information by processing information received from existing medical imaging equipment with its patented and own methods incorporating Knowledge-Based Reconstruction (KBR) algorithms and own cardiac databases. Its KBR method allows for the creation of a 3D model of the right and/or left ventricle using images generated from existing two-dimensional imaging equipment.

Website: ventripoint.com
Social

Key Metrics

Founded Year

2005

Location

Toronto, Canada

Stage

Public

Latest Funding Round

Post IPO, Feb 04, 2025, $*****

Ranked

5^th among 73 active competitors

Employee Count

49 as on May 27, 2025

Similar Companies

Eko & 91 more

Exit Details

Public

View VentriPoint's full profile

VentriPoint is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
VentriPoint Diagnostics Ltd CIN: 1414336 , United States, Active		$1 - $1M (As on Aug 08, 2013)	-	-

VentriPoint got listed on Nov 09, 2005.

Click here to take a look at VentriPoint's IPO in detail

VentriPoint has raised funding over 17 rounds. Its first funding round was on Mar 30, 2010.

Here is the list of recent funding rounds of VentriPoint:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Feb 04, 2025	6969571	Post IPO	3867050	2850277	8498605	1238473
Jan 09, 2025	4773385	Post IPO	6377176	2200262	4752825	1179392
Dec 16, 2024	9651101	Post IPO	2500666	3558783	2571636	2552383

Access funding benchmarks and valuations. Sign up today!

View details of VentriPoint's funding rounds and investors

VentriPoint's employee count trend

VentriPoint has 49 employees as of May 25. Here is VentriPoint's employee count trend over the years:

Uncover VentriPoint's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of VentriPoint include Eko, HeartFlow and Cleerly. Here is the list of Top 10 competitors of VentriPoint, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Eko 2012, Oakland (United States), Series D	Provider of AI-based remote patient monitoring platform for cardiac health	$195M	Artis Ventures, Peak XV Partners & 33 others	72/100
2nd	HeartFlow 2007, Redwood City (United States), Public	Provides cardiovascular diagnostic support using analytics	$936M	Wellington, Bain Capital Life Sciences & 22 others	67/100
3rd	Cleerly 2016, Denver (United States), Series C	Provider of an AI-driven platform for coronary artery disease assessment	$578M	T. Rowe Price, Fidelity Investments & 20 others	63/100
4th	Lantheus 2008, Billerica (United States), Public	Developer of diagnostic imaging agents and targeted therapeutics	-	HealthCare Royalty Partners, HHS	59/100
5th	VentriPoint 2005, Toronto (Canada), Public	Heart analysis system	-	-	56/100
6th	Arterys 2012, San Francisco (United States), Series C	Developer of cloud-based AI platform for medical imaging analysis	$70.2M	Temasek, Emergent Medical Partners & 14 others	55/100
7th	HeartSciences 2007, Austin (United States), Public	Provider of a screening device for the early detection of cardiac dysfunction	$31.7M	-	53/100
8th	LifeLens 2014, Warminster (United States), Series B	Developer of wireless ECG monitor for personal health monitoring use	$39.7M	Paragon Equity Partners, Brightstone Venture Capital ... Read more	52/100
9th	Cardiac Insight 2008, Bellevue (United States), Series D	Cardiac diagnostics for sports medicine	$37.2M	SeaChange Fund, Welch Allyn & 8 others	48/100
10th	CardioNet 1999, Conshohocken (United States), Public	Provider of outpatient management solutions for monitoring clinical information	$142M	Saints Capital, Ballast Point Ventures & 6 others	48/100